AU2003262025A1 - Preparation for controlling binging of drug to plasma protein - Google Patents

Preparation for controlling binging of drug to plasma protein

Info

Publication number
AU2003262025A1
AU2003262025A1 AU2003262025A AU2003262025A AU2003262025A1 AU 2003262025 A1 AU2003262025 A1 AU 2003262025A1 AU 2003262025 A AU2003262025 A AU 2003262025A AU 2003262025 A AU2003262025 A AU 2003262025A AU 2003262025 A1 AU2003262025 A1 AU 2003262025A1
Authority
AU
Australia
Prior art keywords
binging
drug
preparation
controlling
plasma protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003262025A
Other languages
English (en)
Inventor
Keiichi Kawai
Norito Takamura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Medi Physics Co Ltd
Original Assignee
Nihon Medi Physics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Medi Physics Co Ltd filed Critical Nihon Medi Physics Co Ltd
Publication of AU2003262025A1 publication Critical patent/AU2003262025A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2003262025A 2002-09-12 2003-09-09 Preparation for controlling binging of drug to plasma protein Abandoned AU2003262025A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2002/267010 2002-09-12
JP2002267010 2002-09-12
PCT/JP2003/011516 WO2004024188A1 (fr) 2002-09-12 2003-09-09 Preparation permettant de reguler la liaison d'un medicament a une proteine plasmatique

Publications (1)

Publication Number Publication Date
AU2003262025A1 true AU2003262025A1 (en) 2004-04-30

Family

ID=31986678

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003262025A Abandoned AU2003262025A1 (en) 2002-09-12 2003-09-09 Preparation for controlling binging of drug to plasma protein

Country Status (4)

Country Link
JP (1) JPWO2004024188A1 (fr)
AU (1) AU2003262025A1 (fr)
TW (1) TWI306762B (fr)
WO (1) WO2004024188A1 (fr)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4296119A (en) * 1978-04-24 1981-10-20 Massachusetts Institute Of Technology Process and composition for reducing blood pressure in animals
US4374857A (en) * 1982-01-25 1983-02-22 Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence Method of inhibiting L-tryptophan to serum albumin binding
JPS60208911A (ja) * 1984-03-28 1985-10-21 Green Cross Corp:The ジアゼパム直腸投与製剤
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
IL105553A (en) * 1992-05-06 1998-01-04 Janssen Pharmaceutica Inc Solid dosage forms consisting of a porous network of matrix that releases a substance that dissipates rapidly in water
JP3383704B2 (ja) * 1993-04-02 2003-03-04 わかもと製薬株式会社 安定なリポソーム水分散液
JPH07267855A (ja) * 1994-03-30 1995-10-17 Taiho Yakuhin Kogyo Kk グルタミン産生剤
JPH0920656A (ja) * 1995-07-06 1997-01-21 Otsuka Pharmaceut Factory Inc アミノ酸輸液製剤
JP4276377B2 (ja) * 1997-08-14 2009-06-10 富士フイルムＲｉファーマ株式会社 安定な放射性医薬品
HUP9701554D0 (en) * 1997-09-18 1997-11-28 Human Oltoanyagtermeloe Gyogys Pharmaceutical composition containing plazma proteins
DE69919155T2 (de) * 1998-05-15 2005-08-04 Chugai Seiyaku K.K. Formulierungen zur mehrfachfreisetzung
US6867193B1 (en) * 1999-01-19 2005-03-15 Nipro Corporation Amino acid-containing albumin preparation
JP4343473B2 (ja) * 1999-06-21 2009-10-14 日本メジフィジックス株式会社 血漿蛋白質に結合親和性を有する薬剤の投与方法並びに当該投与方法に用いられる製剤
JP4101418B2 (ja) * 1999-12-03 2008-06-18 田辺三菱製薬株式会社 総合栄養輸液剤

Also Published As

Publication number Publication date
WO2004024188A1 (fr) 2004-03-25
JPWO2004024188A1 (ja) 2006-01-05
TWI306762B (en) 2009-03-01
TW200404577A (en) 2004-04-01

Similar Documents

Publication Publication Date Title
AU2003272590A1 (en) Method for ophtalmic administration of medicament
AU2003242566A1 (en) Production of olefins
AU2003222067A1 (en) System for delivery of therapeutic substances
AU2003239367A1 (en) Actuator for two angular degrees of freedom
AU2002362710A1 (en) Use of thymulin-like peptides for making pain-relieving medicines
AU2003255982A1 (en) Preparation of microcapsules
AU2003255456A1 (en) Production of olefins
AU2003292263A1 (en) Use of substituted 2-phenylbenzimidazoles as medicaments
AU2003268687A1 (en) Novel salt of 2-acylaminothiazole derivative
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
AU2003257536A1 (en) Method of stabilizing protein solution preparation
AU2002950657A0 (en) Derivatives of monosaccharides for drug discovery
AU2003230566A1 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
AU2003217900A1 (en) Preparation of unsaturated polyesters
AU2003260813A1 (en) Improved process for preparation of thiazolidinedione derivatives
AU2003265373A1 (en) Preparation of aztreonam
AU2003202872A1 (en) Preparation of nano-sized crystals
AU2003246614A1 (en) Novel use of lipopeptide preparations
AU2003262025A1 (en) Preparation for controlling binging of drug to plasma protein
AU2003262141A1 (en) Preperation of desloratatine
AU2002950183A0 (en) Expression of hydrophobic proteins
AU2003298725A1 (en) Preparation of metallotexaphyrins
AU2003256006A1 (en) Improved process for preparation of risperidone
AU2003219507A1 (en) Process for the preparation of highly pure torsemide
AU2003250329A1 (en) Regulation of novel human asparagine-hydroxylases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase